ÂÜÀòÂÒÂ×

The Leadership Team at KSQ Therapeutics drives the strategic vision and operational execution of the company, ensuring effective collaboration across discovery, clinical, and financial domains. Comprising executives with expertise in biology, clinical sciences, and finance, this team steers the development of the CRISPRomics platform to advance precision therapeutics, overseeing research priorities, funding strategies, and regulatory compliance to ultimately transform genomic insights into actionable treatments for diseases.